
Liveo is owned by DuPont de Nemours, Inc. (NYSE: DD), a publicly traded American materials company headquartered in Wilmington, Delaware. Launched in 2020 on the healthcare silicones business DuPont inherited from Dow Corning, Liveo supplies medical-grade silicone adhesives, elastomers, and fluids for wearables, wound care, transdermal drug delivery, and medical devices.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Liveo | DuPont | Product line |
The chemistry predates the name by nearly 80 years. Dow Corning, the Dow-Corning Glass joint venture founded in 1943, built the healthcare silicones business that produced medical adhesives, elastomers, and tubing used across implantable and external devices. That portfolio passed to Dow in 2016 when the joint venture unwound.
In 2019, the DowDuPont separation moved the healthcare silicones into the new DuPont's medical business, which already included the 2019-acquired Spectrum plastics operations and later the Donatelle medical device manufacturing unit. DuPont introduced the Liveo name in 2020 as the healthcare-facing silicone brand, giving regulatory documentation, quality systems, and product designations a single umbrella.
Investment followed the rebrand. DuPont opened a dedicated Liveo medical-grade silicone adhesives plant in the Cooper River area of South Carolina in 2022 and announced capacity expansions for biopharmaceutical silicones at its Zhangjiagang, China site the same year. The brand's adhesives now cover transdermal patches, wearable sensors, wound care, and ostomy applications, with DuPont stating that silicone transdermal patches on the market use Liveo adhesives.
Who owns DuPont?
DuPont is a publicly traded company listed on the New York Stock Exchange under the ticker symbol DD. The company is owned by its shareholders, including institutional investors, mutual funds, and individual investors. The company is governed by a 13-member Board of Directors led by Executive Chairman Edward D. Breen and CEO Lori Koch.
Is DuPont publicly traded?
Yes, DuPont is publicly traded on NYSE under the ticker symbol DD. The company reported FY2025 continuing operations net sales of $6.85 billion and adjusted EPS of $1.68. In Q2 2026, net sales were $1.82 billion with adjusted EPS of $1.88. A 1-for-3 reverse stock split became effective on June 24, 2026.
Who is the CEO of DuPont?
Lori Koch has served as CEO of DuPont since June 2024, succeeding Edward D. Breen, who transitioned to Executive Chairman. Koch has guided the company through its Electronics separation into Qnity Electronics (completed November 2025) and the sale of its Aramids business (completed April 2026).
When was DuPont founded?
DuPont was founded in 1802 by Eleuthere Irenee du Pont, a French-American chemist who established a gunpowder mill on the Brandywine Creek near Wilmington, Delaware. The company has operated for over 220 years and is one of America's oldest continuously operating industrial companies.
What is DuPont's annual revenue?
DuPont reported FY2025 continuing operations net sales of $6.85 billion, up 2% from $6.72 billion in FY2024. Operating EBITDA was $1.63 billion with a 23.8% margin. For FY2026, the company guides to net sales of $7.16 to $7.19 billion and adjusted EPS of $7.17 to $7.32. In Q2 2026, net sales were $1.82 billion, up 4% year-over-year.
What brands does DuPont own?
DuPont's brand portfolio includes Tyvek (protective materials and building wraps), FilmTec (water treatment membranes), AmberLite (ion exchange resins), BETAMATE (structural adhesives), BETATECH (thermal interface materials), Pyralux (flexible circuit materials), Kalrez (perfluoroelastomer seals), and Vamac (elastomers). The company sold its Aramids brands including Kevlar and Nomex to Arclin in April 2026.
What happened to DuPont's Electronics business?
DuPont completed the separation of its Electronics business into Qnity Electronics, Inc. on November 1, 2025, through a tax-free distribution of Qnity common stock to DuPont shareholders of record as of October 22, 2025. Qnity now operates as an independent public company. DuPont initially planned to separate into three companies but decided in January 2025 to retain its Water business.
What controversies has DuPont faced?
DuPont has faced significant PFAS-related litigation, resulting in a settlement with the State of New Jersey totaling $875 million over 25 years (shared with Chemours and Corteva). The company also faces ongoing environmental compliance scrutiny related to historical chemical manufacturing. The Electronics separation and Aramids divestiture involved complex liability allocations, including certain PFAS liabilities assumed by Qnity Electronics.
The brand operates under pharmaceutical-grade quality requirements: ISO 13485-aligned medical device material production, USP Class VI and ISO 10993 biocompatibility testing, and master file registrations with regulators. These are table stakes for the category and the substance of its compliance profile.
DuPont reports the healthcare business within its corporate sustainability program, including low-VOC silicone development and energy reduction targets at the Hemlock and Cooper River plants. The brand has no independent consumer-facing certifications; its credentials are regulatory and technical.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Boston Scientific | USA | 1979 | Mass market | Global | All Genders | |
| Ge Healthcare | USA | 2023 | Mass market | Global | All Genders | |
| Medtronic | USA | 2021 | Mass market | Global | All Genders | |
| Intuitive Surgical | USA | 1995 | Mass market | Global | All Genders | |
| Medtronic | USA | 1949 | Mass market | Global | All Genders | |
| Medtronic | USA | 2015 | Mass market | Global | All Genders |
Healthcare PharmaceuticalsOwned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Medical imaging equipment brand of GE HealthCare, covering MRI, CT, X-ray, and molecular imaging systems used in hospitals and diagnostic centers worldwide.
Healthcare PharmaceuticalsOwned by Medtronic plc
Medtronic's Hugo robotic-assisted surgery system for soft-tissue procedures, FDA cleared for urologic surgery in December 2025.
Healthcare PharmaceuticalsOwned by Intuitive Surgical, Inc.
The corporate brand of Intuitive Surgical, Inc., the Sunnyvale company behind the da Vinci robotic surgery systems and Ion bronchoscopy platform.
Healthcare PharmaceuticalsOwned by Medtronic plc
Flagship brand of Medtronic plc, the world's largest medical device company, covering pacemakers, heart valves, spinal implants, and surgical technology.
Healthcare PharmaceuticalsOwned by Medtronic plc
Medtronic's Micra leadless pacemaker family, the world's smallest pacemakers, implanted directly in the heart and used in more than 300,000 patients.
Market Positioning: Liveo competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by DuPont, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by HCA Healthcare, Inc.
HCA Healthcare is the flagship brand of the largest U.S. for-profit hospital operator, a network of 190 hospitals and about 2,500 ambulatory sites across 19 states and England.
HCA Healthcare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Pfizer Inc.
American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.
Pfizer operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
Philips operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Zimmer Biomet Holdings, Inc.
Zimmer Biomet is the flagship orthopedic brand of Zimmer Biomet Holdings, producing knee, hip, and trauma implants plus the ROSA surgical robotics platform from its Warsaw, Indiana base.
Zimmer Biomet operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Regeneron Pharmaceuticals, Inc.
Biotechnology brand of Regeneron Pharmaceuticals, developer of Eylea, Dupixent, and Libtayo, headquartered in Tarrytown, New York.
Regeneron operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.